Mylan N.V. (MYL) - 5i Research

Mylan N.V. (MYL $15.86)
- $15.86 Cap: $8.58B
- View MYL Profile
- View Questions on MYL

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Mylan N.V. (MYL $15.86)
- $15.86 Cap: $8.58B
- View MYL Profile
- View Questions on MYL
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA $16.58)
- $16.58 Cap: $19.01B
- View TEVA Profile
- View Questions on TEVA
Dr. Reddy's Laboratories Ltd (RDY $14.60)
- $14.60 P/E (TTM): 18.25X Cap: $12.18B
- View RDY Profile
- View Questions on RDY
Taro Pharmaceutical Industries Ltd. (TARO)
- P/E (TTM): 30.05X Cap: $1.61B
- View TARO Profile
- View Questions on TARO

Q: I am interested in buying a generic drug maker at this time. Which would you recommend ( TEVA or RDY). Would appreciate your recommendation if you don’t like these two.
Thanks

Read Answer Asked by satish on March 13, 2019

Mylan N.V. (MYL $15.86)
- $15.86 Cap: $8.58B
- View MYL Profile
- View Questions on MYL

Q: Hi Peter
can you revisit this company . Is it a buy at this point ?

Read Answer Asked by Candi on June 19, 2017

Mylan N.V. (MYL $15.86)
- $15.86 Cap: $8.58B
- View MYL Profile
- View Questions on MYL

Q: Myl
Hi Peter
Can you revisit Mylan for me . Do you still consider it a hold?

Read Answer Asked by Candi on April 28, 2014